In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle.
about
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyondNon-Viral Nucleic Acid Delivery Strategies to the Central Nervous SystemSelf-assembled Messenger RNA Nanoparticles (mRNA-NPs) for Efficient Gene Expression.Messenger RNA-based therapeutics for the treatment of apoptosis-associated diseases.Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment.Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animalsNucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.Messenger RNA (mRNA) nanoparticle tumour vaccinationScreening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity.Viral and Synthetic RNA Vector Technologies and Applications.Bulk and nanoscale polypeptide based polyelectrolyte complexes.Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA.Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis.Efficient expression of stabilized mRNA PEG-peptide polyplexes in liver.Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.Novel Platforms for the Development of a Universal Influenza Vaccine.
P2860
Q26861563-23D686DB-A85C-4DE6-8563-868B739BE233Q28068242-24F404C9-4681-4569-9138-40366F2F81E2Q35909697-2E819181-E24D-45D9-B12D-16D2A8D13718Q36216226-1C67D8C6-B98B-4609-B329-31A80BCBA89CQ36428199-0E30359B-9A07-4C70-A61D-0FB1FEF08A01Q37612455-1AA5CB53-13EF-46EA-A0F4-DC776FF5BAA6Q38199151-BDE8637F-37E5-45E8-BA20-22AA7D8C21D5Q38218147-62006DB1-4481-49EC-94E2-67A8CBFC96D8Q38848999-6C8DCCE2-36B5-41AF-B6C0-CCC770DC9B65Q38885624-AD72399F-9412-4809-811D-765FCC7DE13FQ38897421-3FFF1413-8C04-431B-B096-AFF82183A91DQ39091854-FB3EDCC9-8E76-4C62-9846-B04B1A8EB88AQ40540556-5006A839-606D-4FD2-B2D6-08A3B1A8BD50Q41436367-ADDB6E5D-E0D8-43E7-AD22-BEB1DD256463Q42642506-B1632152-CCDE-4E18-BD2D-BD74D6904E71Q50056652-3A81C2FE-07B9-4F96-B5A1-8865878F24DCQ52599675-FC61F959-7112-4C45-A6CC-5BB962CECDF6
P2860
In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
In vivo messenger RNA introduc ...... em using polyplex nanomicelle.
@ast
In vivo messenger RNA introduc ...... em using polyplex nanomicelle.
@en
In vivo messenger RNA introduc ...... em using polyplex nanomicelle.
@nl
type
label
In vivo messenger RNA introduc ...... em using polyplex nanomicelle.
@ast
In vivo messenger RNA introduc ...... em using polyplex nanomicelle.
@en
In vivo messenger RNA introduc ...... em using polyplex nanomicelle.
@nl
prefLabel
In vivo messenger RNA introduc ...... em using polyplex nanomicelle.
@ast
In vivo messenger RNA introduc ...... em using polyplex nanomicelle.
@en
In vivo messenger RNA introduc ...... em using polyplex nanomicelle.
@nl
P2093
P2860
P1433
P1476
In vivo messenger RNA introduc ...... em using polyplex nanomicelle.
@en
P2093
Hirokuni Uchida
Kazunori Kataoka
Keiji Itaka
Kentaro Hayakawa
Shigeto Fukushima
Takehiko Ishii
Toru Ogata
P2860
P304
P356
10.1371/JOURNAL.PONE.0056220
P407
P577
2013-02-13T00:00:00Z